Episode 3.3 When should we use new treatments? Jada And cfDNA
In this episode we discuss the new Jada postpartum hemorrhage device. More importantly, we discuss the process for choosing to utilize new interventions in clinical practice. Then we discuss a recent New York Times article detailing the problem of false positives in the noninvasive prenatal screening tests.
Follow us on Instagram @thinkingaboutobgyn.
Create your
podcast in
minutes
It is Free